Bis(4-tert-butylphenyl)iodonium hexafluorophosphate(CAS#61358-25-6)
Bis(4-tert-butylphenyl)iodonium hexafluorophosphate (BPIHFP) is a symmetrical diaryliodonium salt in which a central hypervalent iodine atom bears two 4-tert-butylphenyl groups as cations and a hexafluorophosphate (PF₆⁻) counterion. It is supplied as a white to almost white crystalline powder with a molecular weight of approximately 538.30 g/mol and a melting point of 172–177 °C with decomposition. The compound is insoluble in water but dissolves in polar organic solvents including ethanol, methanol, acetone, acetonitrile, and DMSO, a solubility profile that supports its incorporation into both solvent-borne and 100% solids resin systems.
The cationic iodonium center is the photochemically active chromophore. Upon UV irradiation, the diaryliodonium cation undergoes homolytic or heterolytic cleavage to generate a strong Brønsted acid—hexafluorophosphoric acid (HPF₆)—together with aryl radicals and iodobenzene-derived byproducts. This photoacid generation is the mechanistic basis for both cationic polymerization of epoxides, vinyl ethers, and oxetanes, and, in hybrid systems, radical polymerization of acrylate monomers. The PF₆⁻ counterion is chosen for its non-coordinating character, which maximizes the acidity and mobility of the photogenerated acid while maintaining thermal stability of the salt. BPIHFP is light-sensitive and moisture-sensitive; it should be stored under an inert gas in tightly closed containers protected from light to prevent premature acid generation and hydrolytic degradation.
Applications
The primary application of BPIHFP is as a cationic photoinitiator and photoacid generator (PAG) for UV- and LED-curable resin systems. It is used at typical loadings of 0.5–5 wt% in formulations cured by exposure to UV light or, when sensitized with thioxanthone derivatives, by LED irradiation. The photogenerated HPF₆ initiates ring-opening cationic polymerization of epoxy resins, oxetanes, and vinyl ethers, enabling rapid cure without the oxygen inhibition that complicates radical polymerization.
In coatings, inks, and adhesives, BPIHFP provides through-cure and surface cure in industrial coatings, pigmented systems, and specialty inks. Its cationic mechanism is particularly valued in thick-section and pigmented formulations where UV penetration is limited, because the photogenerated acid continues to propagate after irradiation ceases (a “dark cure” effect). In adhesives and sealants, the compound improves curing speed and bond performance, with relevance to automotive and construction applications requiring durable bonds.
A growing application is in 3D printing and additive manufacturing, where BPIHFP serves as the photoacid generator in cationic stereolithography and digital light processing resins. Its thermal stability and solubility in resin monomers make it compatible with the elevated temperatures and extended storage times encountered in print engines. In semiconductor photolithography, diaryliodonium PF₆ salts function as PAGs in chemically amplified resist (CAR) platforms, where the photogenerated acid catalyzes deprotection reactions that define the patterned image; BPIHFP contributes to high-resolution patterning relevant to microelectronics fabrication. The compound is also employed in organic synthesis as an arylating reagent and in biomedical coating research, where photo-triggered cationic polymerization enables spatial control of material properties.
Preparation Method
The synthesis of BPIHFP proceeds in two stages: construction of the diaryliodonium cation and counterion exchange to the hexafluorophosphate salt.
In the first stage, tert-butylbenzene is reacted with elemental iodine in the presence of an oxidant and an acid promoter. A representative patent procedure charges 16.1 g of tert-butylbenzene, 5.1 g of elemental iodine, 10.3 g of *p*-toluenesulfonic acid, and 50 mL of dichloroethane to a round-bottomed flask, followed by slow addition of 10.3 g of 50% hydrogen peroxide. The mixture is heated at 60 °C for 48 hours to effect oxidative coupling, yielding the intermediate bis(4-tert-butylphenyl)iodonium *p*-toluenesulfonate after filtration and work-up.
In the second stage, the *p*-toluenesulfonate intermediate is dissolved in ethanol and treated with a saturated aqueous solution of potassium hexafluorophosphate (KPF₆) at room temperature. The PF₆⁻ anion exchanges with the tosylate anion, and the sparingly soluble BPIHFP precipitates from the ethanolic medium. The solid is collected by suction filtration to afford the final product; the reported overall yield for this two-step sequence is approximately 69%.
Safety Information
The GHS classification of BPIHFP varies across suppliers and regulatory frameworks, and users should consult the specific SDS accompanying their material.
Several authoritative classifications assign Skin Corrosion Category 1B with the hazard statement H314 (Causes severe skin burns and eye damage) and the signal word Danger (EU CLP, Sigma-Aldrich). Some OSHA-aligned assessments additionally list H318 (Causes serious eye damage). Other supplier classifications (TCI) assign the lower-severity statements H315 (Causes skin irritation) and H319 (Causes serious eye irritation) with the signal word Warning. The NFPA 704 health rating is reported as 3, indicating that short exposure could cause serious temporary or moderate residual injury. Regardless of the classification tier, the material should be handled with the presumption of corrosive hazard.
A critical and distinctive safety consideration for BPIHFP and other hexafluorophosphate salts is the potential for fluoride-mediated injury. On contact with moisture or tissue, PF₆⁻ can liberate fluoride ion, and the SDS explicitly warns that hydrofluoric (HF) acid burns require immediate and specialized first aid and medical treatment, with symptoms that may be delayed up to 24 hours. Skin exposures should be treated with 2.5% calcium gluconate gel applied repeatedly until burning ceases; more serious exposures may require subcutaneous calcium gluconate administration under medical supervision. Ingestion of fluoride can cause hypocalcemia, hypomagnesemia, and cardiac arrhythmias, and conscious victims may be given milk, chewable calcium carbonate tablets, or Milk of Magnesia to bind fluoride ion. This fluoride-specific first-aid protocol should be communicated to all personnel before handling.
For routine handling, avoid generating and inhaling dust, and use local exhaust ventilation at points where dust may form. Wear protective gloves, protective clothing, and eye/face protection (P280). In case of eye contact, rinse cautiously with water for at least 15 minutes and call a poison center or physician immediately (P305+P351+P338, P310). For skin contact, remove contaminated clothing immediately and rinse with water/shower; apply calcium gluconate paste as directed and call a physician immediately. BPIHFP is light-sensitive, moisture-sensitive, and hygroscopic; store under inert gas in tightly closed containers in a dry, light-protected area (storage class 8A). In case of fire, decomposition may release hydrogen fluoride, hydrogen iodide, phosphorus oxides, and carbon oxides; firefighters should wear self-contained breathing apparatus. The compound is not classified as hazardous for transportation under DOT/IATA criteria in some supplier assessments, but this should be confirmed against the specific SDS and applicable regulations for the grade supplied.








